Adalimumab (Subcutaneous Route)


Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Adalimumab (Subcutaneous Route)

Drug Information provided by: Micromedex

US Brand Names

  • Humira

Description

Adalimumab injection is used to treat the symptoms and prevent the progression of active rheumatoid arthritis and ankylosing spondylitis. It is used in children 4 years of age and older for juvenile idiopathic arthritis. This medicine is also used to treat psoriatic arthritis, which is a type of arthritis that causes pain and swelling in the joints along with patches of scaly skin on some areas of the body. Psoriatic arthritis usually occurs with a skin condition called psoriasis. Adalimumab may be used alone or in combination with medicines such as methotrexate.

Adalimumab injection is also used to treat the symptoms of active Crohn's disease in patients who have not been helped by other medicines, such as infliximab. It is also used to treat moderate to moderate to severe ulcerative colitis in patients who have been treated with other medicines (e.g., azathioprine, corticosteroids, or 6-mercaptopurine) that did not work well.

Adalimumab injection may also be used to treat chronic plaque psoriasis, which is a skin disease with red patches and white scales that don't go away.

This medicine is available only with your doctor's prescription.

This product is available in the following dosage forms:

  • Solution
Before Using
DR601467 Portions of this document last updated: Nov. 1, 2012

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger